Do Common Variants Separate Between Obese Melanocortin-4 Receptor Gene Mutation Carriers and Non-Carriers? the Impact of Cryptic Relatedness.

Jessica Muehlhaus,Carolin Puetter,Harald Brumm,Harald Grallert,Thomas Illig,Susann Scherag,Thomas Reinehr,Wilfried Pott,Oezguer Albayrak,Hai-Jun Wang,Anne-Madeleine Bau,Susanna Wiegand,Annette Grueters,Heiko Krude,Johannes Hebebrand,Anke Hinney,Heike Biebermann,Andre Scherag
DOI: https://doi.org/10.1159/000338999
2012-01-01
Hormone Research in Paediatrics
Abstract:Background/Aims: Genome-wide association studies revealed associations of single nucleotide polymorphisms (SNPs) flanking MC4R with body mass index variability and obesity. We genotyped 28 SNPs, covering MC4R, and searched for haplotypes discriminating between obese mutation carriers and non-carriers. Methods: We analyzed all three-marker haplotype combinations of the 28 SNPs to discriminate between obese mutation carriers and non-carriers - overall and in functional categories for 25 different MC4R mutations: (a) 'like wild type', (b) 'partial loss of function', and (c) 'complete loss of function'. We checked for the possible impact of 'cryptic relatedness' by sensitivity analyses including only 1 randomly selected patient per mutation. Results: Overall analyses revealed a haplotype of 3 SNPs downstream of the MC4R discriminating between obese mutation carriers and obese non-carriers. However, sensitivity analyses showed that the finding is most likely due to cryptic relatedness. Conclusion: Given a mutation prevalence of 1-5%, the sample size of 62 obese mutation carriers with overall 25 different MC4R mutations represents a unique feature of our study. Taking MC4R as an example, we demonstrate the impact of cryptic relatedness when trying to link non-coding SNPs to functionally relevant mutations. Hence, a thorough mutation screen can currently not be guided by SNP genotyping. Copyright (C) 2012 S. Karger AG, Basel
What problem does this paper attempt to address?